Sagimet Biosciences (SGMT) Institutional Ownership → Are You Positioned For The New Energy Goldrush? (From Wealthpin Pro) (Ad) Free SGMT Stock Alerts $5.47 +0.30 (+5.80%) (As of 05/29/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Sagimet Biosciences (NASDAQ:SGMT)CurrentInstitutional OwnershipPercentage87.86%Number ofInstitutional Buyers(last 12 months)17TotalInstitutional Inflows(last 12 months)$51.58MNumber ofInstitutional Sellers(last 12 months)5TotalInstitutional Outflows(last 12 months)$17.03M Get SGMT Insider Trade Alerts Want to know when executives and insiders are buying or selling Sagimet Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data SGMT Institutional Buying and Selling by Quarter Ad Wealthpin ProAre You Positioned For The New Energy Goldrush?Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it. Sagimet Biosciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/17/2024 Artal Group S.A.724,771$3.93M0.1%-21.6%2.271% 5/17/2024 Ikarian Capital LLC412,565$2.24M0.2%N/A1.293% 5/15/2024 Baker BROS. Advisors LP1,381,898$7.49M0.1%-5.1%4.331% 5/15/2024 NEA Management Company LLC2,000,275$10.84M0.7%-48.0%6.268% 5/15/2024 Price T Rowe Associates Inc. MD16,705$91K0.0%N/A0.052% 5/15/2024 Hhlr Advisors LTD.724,800$3.93M0.1%-50.0%2.271% Get the Latest News and Ratings for SGMT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sagimet Biosciences and its competitors with MarketBeat's FREE daily newsletter. 5/14/2024 Platinum Investment Management Ltd.90,633$491K0.0%-18.9%0.284% 5/14/2024 American International Group Inc.11,372$62K0.0%+312.0%0.036% 5/13/2024 O Shaughnessy Asset Management LLC13,344$72K0.0%N/A0.042% 5/10/2024 Acadian Asset Management LLC34,929$188K0.0%N/A0.109% 5/10/2024 Vanguard Group Inc.1,139,407$6.18M0.0%+364.9%3.570% 2/14/2024 Platinum Investment Management Ltd.111,752$606K0.0%-70.9%0.523% 2/5/2024 Victory Capital Management Inc.56,570$307K0.0%+215.0%0.265% 1/31/2024 Federated Hermes Inc.97,276$527K0.0%+24.7%0.455% 11/15/2023 RTW Investments LP400,277$3.52M0.1%N/A1.875% 11/15/2023 Rock Springs Capital Management LP738,355$6.50M0.2%N/A3.458% 11/14/2023 Dumac Inc.204,123$1.80M4.8%N/A0.956% 11/13/2023CHI Advisors LLC348,842$3.07M0.9%N/A1.634% 11/13/2023 Federated Hermes Inc.78,000$686K0.0%N/A0.365% 11/13/2023 Silverarc Capital Management LLC100,000$880K0.3%N/A0.468% 11/13/2023 FMR LLC2,672,355$23.52M0.0%N/A12.517% 11/7/2023 New York State Common Retirement Fund6,357$56K0.0%N/A0.030% 11/6/2023 Victory Capital Management Inc.17,960$158K0.0%N/A0.084% 11/3/2023 Platinum Investment Management Ltd.383,913$3.38M0.1%N/A1.798% 10/31/2023 Teacher Retirement System of Texas25,000$220K0.0%N/A0.117% (Data available from 1/1/2016 forward) SGMT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SGMT shares? During the previous two years, 21 institutional investors and hedge funds held shares of Sagimet Biosciences. The most heavily invested institutionals were FMR LLC ($23.52M), NEA Management Company LLC ($10.84M), Baker BROS. Advisors LP ($7.49M), Rock Springs Capital Management LP ($6.50M), Vanguard Group Inc. ($6.18M), Artal Group S.A. ($3.93M), and Hhlr Advisors LTD. ($3.93M).Learn more on SGMT's institutional investors. What percentage of Sagimet Biosciences stock is owned by institutional investors? 87.86% of Sagimet Biosciences stock is owned by institutional investors. Learn more on SGMT's institutional investor holdings. Which institutional investors have been buying Sagimet Biosciences stock? Of the 17 institutional investors that purchased Sagimet Biosciences stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: FMR LLC ($2.67M), Vanguard Group Inc. ($894.32K), Rock Springs Capital Management LP ($738.36K), Ikarian Capital LLC ($412.57K), RTW Investments LP ($400.28K), Platinum Investment Management Ltd. ($383.91K), and CHI Advisors LLC ($348.84K). How much institutional buying is happening at Sagimet Biosciences? Institutional investors have bought a total of 6,413,542 shares in the last 24 months. This purchase volume represents approximately $51.58M in transactions. Which Sagimet Biosciences major shareholders have been selling company stock? The following institutional investors have sold Sagimet Biosciences stock in the last 24 months: NEA Management Company LLC ($1.85M), Hhlr Advisors LTD. ($724.74K), Platinum Investment Management Ltd. ($293.28K), Artal Group S.A. ($200K), and Baker BROS. Advisors LP ($74.62K). How much institutional selling is happening at Sagimet Biosciences? Institutional investors have sold a total of 3,142,643 shares in the last 24 months. This volume of shares sold represents approximately $17.03M in transactions. Related Companies: CytomX Therapeutics Institutional Ownership Context Therapeutics Institutional Ownership ProQR Therapeutics Institutional Ownership Gossamer Bio Institutional Ownership RAPT Therapeutics Institutional Ownership Alimera Sciences Institutional Ownership Syros Pharmaceuticals Institutional Ownership InterCure Institutional Ownership Cybin Institutional Ownership Rigel Pharmaceuticals Institutional Ownership This page (NASDAQ:SGMT) was last updated on 5/30/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceWrite this ticker symbol down…StocksToTradeThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarBiden Nomination CANCELED?The Freeport SocietyBUY ALERT: Tiny tech play partners with US governmentStansberry ResearchGold Set to EXPLODE!Gold Safe Exchange[Urgent!] Generational Wealth GameplanCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sagimet Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.